TY - JOUR AU - Chalasani, N. AU - Younossi, Z. AU - Lavine, J. E. AU - Charlton, M. AU - Cusi, K. AU - Rinella, M. AU - Harrison, S. A. AU - Brunt, E. M. AU - Sanyal, A. J. PY - 2018 DA - 2018// TI - The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases JO - Hepatology VL - 67 UR - https://doi.org/10.1002/hep.29367 DO - 10.1002/hep.29367 ID - Chalasani2018 ER - TY - JOUR AU - Fan, J. G. AU - Wei, L. AU - Zhuang, H. PY - 2019 DA - 2019// TI - Guidelines of prevention and treatment of nonalcoholic fatty liver disease (2018, China) JO - J Dig Dis VL - 20 UR - https://doi.org/10.1111/1751-2980.12685 DO - 10.1111/1751-2980.12685 ID - Fan2019 ER - TY - JOUR AU - Li, J. AU - Zou, B. AU - Yeo, Y. H. PY - 2019 DA - 2019// TI - Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis JO - Lancet Gastroenterol Hepatol VL - 4 UR - https://doi.org/10.1016/S2468-1253(19)30039-1 DO - 10.1016/S2468-1253(19)30039-1 ID - Li2019 ER - TY - JOUR AU - Zhou, F. AU - Zhou, J. AU - Wang, W. AU - Zhang, X. J. AU - Ji, Y. X. AU - Zhang, P. AU - She, Z. G. AU - Zhu, L. AU - Cai, J. AU - Li, H. PY - 2019 DA - 2019// TI - Unexpected rapid increase in the burden of nonalcoholic fatty liver disease in China from 2008 to 2018: a systematic review and meta-analysis JO - Hepatology VL - 70 UR - https://doi.org/10.1002/hep.30702 DO - 10.1002/hep.30702 ID - Zhou2019 ER - TY - JOUR AU - Xiao, J. AU - Bei, Y. AU - Liu, J. PY - 2016 DA - 2016// TI - miR-212 downregulation contributes to the protective effect of exercise against non-alcoholic fatty liver via targeting FGF-21 JO - J Cell Mol Med VL - 20 UR - https://doi.org/10.1111/jcmm.12733 DO - 10.1111/jcmm.12733 ID - Xiao2016 ER - TY - JOUR AU - Mantovani, A. AU - Byrne, C. D. AU - Bonora, E. AU - Targher, G. PY - 2018 DA - 2018// TI - Nonalcoholic fatty liver disease and risk of incident type 2 diabetes: a meta-analysis JO - Diabetes Care VL - 41 UR - https://doi.org/10.2337/dc17-1902 DO - 10.2337/dc17-1902 ID - Mantovani2018 ER - TY - JOUR AU - Targher, G. AU - Day, C. P. AU - Bonora, E. PY - 2010 DA - 2010// TI - Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease JO - N Engl J Med VL - 363 UR - https://doi.org/10.1056/NEJMra0912063 DO - 10.1056/NEJMra0912063 ID - Targher2010 ER - TY - JOUR AU - Xu, C. AU - Yu, C. AU - Ma, H. AU - Xu, L. AU - Miao, M. AU - Li, Y. PY - 2013 DA - 2013// TI - Prevalence and risk factors for the development of nonalcoholic fatty liver disease in a nonobese Chinese population: the Zhejiang Zhenhai study JO - Am J Gastroenterol VL - 108 UR - https://doi.org/10.1038/ajg.2013.104 DO - 10.1038/ajg.2013.104 ID - Xu2013 ER - TY - JOUR AU - Li, Y. AU - Xu, C. AU - Yu, C. AU - Xu, L. AU - Miao, M. PY - 2009 DA - 2009// TI - Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study JO - J Hepatol VL - 50 UR - https://doi.org/10.1016/j.jhep.2008.11.021 DO - 10.1016/j.jhep.2008.11.021 ID - Li2009 ER - TY - JOUR AU - Wan, X. AU - Xu, C. AU - Lin, Y. AU - Lu, C. AU - Li, D. AU - Sang, J. AU - He, H. AU - Liu, X. AU - Li, Y. AU - Yu, C. PY - 2016 DA - 2016// TI - Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism JO - J Hepatol VL - 64 UR - https://doi.org/10.1016/j.jhep.2015.11.022 DO - 10.1016/j.jhep.2015.11.022 ID - Wan2016 ER - TY - JOUR AU - Choi, Y. J. AU - Shin, H. S. AU - Choi, H. S. AU - Park, J. W. AU - Jo, I. AU - Oh, E. S. AU - Lee, K. Y. AU - Lee, B. H. AU - Johnson, R. J. AU - Kang, D. H. PY - 2014 DA - 2014// TI - Uric acid induces fat accumulation via generation of endoplasmic reticulum stress and SREBP-1c activation in hepatocytes JO - Lab Investig VL - 94 UR - https://doi.org/10.1038/labinvest.2014.98 DO - 10.1038/labinvest.2014.98 ID - Choi2014 ER - TY - JOUR AU - Lanaspa, M. A. AU - Sanchez-Lozada, L. G. AU - Choi, Y. J. PY - 2012 DA - 2012// TI - Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver JO - J Biol Chem VL - 287 UR - https://doi.org/10.1074/jbc.M112.399899 DO - 10.1074/jbc.M112.399899 ID - Lanaspa2012 ER - TY - JOUR AU - Mendell, J. T. PY - 2005 DA - 2005// TI - MicroRNAs: critical regulators of development, cellular physiology and malignancy JO - Cell Cycle VL - 4 UR - https://doi.org/10.4161/cc.4.9.2032 DO - 10.4161/cc.4.9.2032 ID - Mendell2005 ER - TY - JOUR AU - Kozomara, A. AU - Birgaoanu, M. AU - Griffiths-Jones, S. PY - 2019 DA - 2019// TI - miRBase: from microRNA sequences to function JO - Nucleic Acids Res VL - 47 UR - https://doi.org/10.1093/nar/gky1141 DO - 10.1093/nar/gky1141 ID - Kozomara2019 ER - TY - JOUR AU - Su, Q. AU - Kumar, V. AU - Sud, N. AU - Mahato, R. I. PY - 2018 DA - 2018// TI - MicroRNAs in the pathogenesis and treatment of progressive liver injury in NAFLD and liver fibrosis JO - Adv Drug Deliv Rev VL - 129 UR - https://doi.org/10.1016/j.addr.2018.01.009 DO - 10.1016/j.addr.2018.01.009 ID - Su2018 ER - TY - JOUR AU - Wu, G. AU - Rui, C. AU - Chen, J. AU - Sho, E. AU - Zhan, S. AU - Yuan, X. AU - Ding, Y. PY - 2017 DA - 2017// TI - MicroRNA-122 inhibits lipid droplet formation and hepatic triglyceride accumulation via yin Yang 1 JO - Cell Physiol Biochem VL - 44 UR - https://doi.org/10.1159/000485765 DO - 10.1159/000485765 ID - Wu2017 ER - TY - JOUR AU - Li, S. AU - Chen, X. AU - Zhang, H. AU - Liang, X. AU - Xiang, Y. AU - Yu, C. AU - Zen, K. AU - Li, Y. AU - Zhang, C. Y. PY - 2009 DA - 2009// TI - Differential expression of microRNAs in mouse liver under aberrant energy metabolic status JO - J Lipid Res VL - 50 UR - https://doi.org/10.1194/jlr.M800509-JLR200 DO - 10.1194/jlr.M800509-JLR200 ID - Li2009 ER - TY - JOUR AU - Ding, J. AU - Li, M. AU - Wan, X. AU - Jin, X. AU - Chen, S. AU - Yu, C. AU - Li, Y. PY - 2015 DA - 2015// TI - Effect of miR-34a in regulating steatosis by targeting PPARalpha expression in nonalcoholic fatty liver disease JO - Sci Rep VL - 5 UR - https://doi.org/10.1038/srep13729 DO - 10.1038/srep13729 ID - Ding2015 ER - TY - JOUR AU - Yu, S. AU - Hong, Q. AU - Wang, Y. PY - 2015 DA - 2015// TI - High concentrations of uric acid inhibit angiogenesis via regulation of the Kruppel-like factor 2-vascular endothelial growth factor-a axis by miR-92a JO - Circ J VL - 79 UR - https://doi.org/10.1253/circj.CJ-15-0283 DO - 10.1253/circj.CJ-15-0283 ID - Yu2015 ER - TY - JOUR AU - Takir, M. AU - Kostek, O. AU - Ozkok, A. PY - 2015 DA - 2015// TI - Lowering uric acid with allopurinol improves insulin resistance and systemic inflammation in asymptomatic Hyperuricemia JO - J Investig Med VL - 63 UR - https://doi.org/10.1097/JIM.0000000000000242 DO - 10.1097/JIM.0000000000000242 ID - Takir2015 ER - TY - JOUR AU - Maratos-Flier, E. PY - 2017 DA - 2017// TI - Fatty liver and FGF21 physiology JO - Exp Cell Res VL - 360 UR - https://doi.org/10.1016/j.yexcr.2017.05.006 DO - 10.1016/j.yexcr.2017.05.006 ID - Maratos-Flier2017 ER - TY - JOUR AU - Rusli, F. AU - Deelen, J. AU - Andriyani, E. AU - Boekschoten, M. V. AU - Lute, C. AU - Akker, E. B. AU - Muller, M. AU - Beekman, M. AU - Steegenga, W. T. PY - 2016 DA - 2016// TI - Fibroblast growth factor 21 reflects liver fat accumulation and dysregulation of signalling pathways in the liver of C57BL/6J mice JO - Sci Rep VL - 6 UR - https://doi.org/10.1038/srep30484 DO - 10.1038/srep30484 ID - Rusli2016 ER - TY - JOUR AU - Xu, C. AU - Yu, C. AU - Xu, L. AU - Miao, M. AU - Li, Y. PY - 2010 DA - 2010// TI - High serum uric acid increases the risk for nonalcoholic fatty liver disease: a prospective observational study JO - PLoS One VL - 5 UR - https://doi.org/10.1371/journal.pone.0011578 DO - 10.1371/journal.pone.0011578 ID - Xu2010 ER - TY - JOUR AU - Afzali, A. AU - Weiss, N. S. AU - Boyko, E. J. AU - Ioannou, G. N. PY - 2010 DA - 2010// TI - Association between serum uric acid level and chronic liver disease in the United States JO - Hepatology VL - 52 UR - https://doi.org/10.1002/hep.23717 DO - 10.1002/hep.23717 ID - Afzali2010 ER - TY - JOUR AU - Sirota, J. C. AU - McFann, K. AU - Targher, G. AU - Johnson, R. J. AU - Chonchol, M. AU - Jalal, D. I. PY - 2013 DA - 2013// TI - Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: liver ultrasound data from the National Health and nutrition examination survey JO - Metab Clin Exp VL - 62 UR - https://doi.org/10.1016/j.metabol.2012.08.013 DO - 10.1016/j.metabol.2012.08.013 ID - Sirota2013 ER - TY - JOUR AU - Huang, Q. AU - Yu, J. AU - Zhang, X. AU - Liu, S. AU - Ge, Y. PY - 2016 DA - 2016// TI - Association of the serum uric acid level with liver histology in biopsy-proven non-alcoholic fatty liver disease JO - Biomed Rep VL - 5 UR - https://doi.org/10.3892/br.2016.698 DO - 10.3892/br.2016.698 ID - Huang2016 ER - TY - JOUR AU - Petta, S. AU - Cammà, C. AU - Cabibi, D. AU - Marco, V. AU - Craxì, A. PY - 2011 DA - 2011// TI - Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease JO - Aliment Pharmacol Ther VL - 34 UR - https://doi.org/10.1111/j.1365-2036.2011.04788.x DO - 10.1111/j.1365-2036.2011.04788.x ID - Petta2011 ER - TY - JOUR AU - Fernández Rodríguez, C. M. AU - Aller, R. AU - Gutiérrez García, M. L. PY - 2019 DA - 2019// TI - Higher levels of serum uric acid influences hepatic damage in patients with non-alcoholic fatty liver disease (NAFLD) JO - Rev Esp Enferm Dig VL - 111 ID - Fernández Rodríguez2019 ER - TY - JOUR AU - Xu, C. F. AU - Yu, C. H. AU - Xu, L. AU - Sa, X. Y. AU - Li, Y. M. PY - 2010 DA - 2010// TI - Hypouricemic therapy: a novel potential therapeutic option for nonalcoholic fatty liver disease JO - Hepatology VL - 52 UR - https://doi.org/10.1002/hep.23798 DO - 10.1002/hep.23798 ID - Xu2010 ER - TY - JOUR AU - Tsai, W. C. AU - Hsu, S. D. AU - Hsu, C. S. PY - 2012 DA - 2012// TI - MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis JO - J Clin Invest VL - 122 UR - https://doi.org/10.1172/JCI63455 DO - 10.1172/JCI63455 ID - Tsai2012 ER - TY - JOUR AU - Zhang, T. AU - Duan, J. AU - Zhang, L. AU - Li, Z. AU - Steer, C. J. AU - Yan, G. AU - Song, G. PY - 2019 DA - 2019// TI - LXRalpha promotes Hepatosteatosis in part through activation of MicroRNA-378 transcription and inhibition of Ppargc1beta expression JO - Hepatology VL - 69 UR - https://doi.org/10.1002/hep.30301 DO - 10.1002/hep.30301 ID - Zhang2019 ER - TY - JOUR AU - Zhang, M. AU - Sun, W. AU - Zhou, M. AU - Tang, Y. PY - 2017 DA - 2017// TI - MicroRNA-27a regulates hepatic lipid metabolism and alleviates NAFLD via repressing FAS and SCD1 JO - Sci Rep VL - 7 UR - https://doi.org/10.1038/s41598-017-15141-x DO - 10.1038/s41598-017-15141-x ID - Zhang2017 ER - TY - JOUR AU - Wang, B. AU - Majumder, S. AU - Nuovo, G. AU - Kutay, H. AU - Volinia, S. AU - Patel, T. AU - Schmittgen, T. D. AU - Croce, C. AU - Ghoshal, K. AU - Jacob, S. T. PY - 2009 DA - 2009// TI - Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice JO - Hepatology VL - 50 UR - https://doi.org/10.1002/hep.23100 DO - 10.1002/hep.23100 ID - Wang2009 ER - TY - JOUR AU - Estep, M. AU - Armistead, D. AU - Hossain, N. AU - Elarainy, H. AU - Goodman, Z. AU - Baranova, A. AU - Chandhoke, V. AU - Younossi, Z. M. PY - 2010 DA - 2010// TI - Differential expression of miRNAs in the visceral adipose tissue of patients with non-alcoholic fatty liver disease JO - Aliment Pharmacol Ther VL - 32 UR - https://doi.org/10.1111/j.1365-2036.2010.04366.x DO - 10.1111/j.1365-2036.2010.04366.x ID - Estep2010 ER - TY - JOUR AU - Zhang, Y. AU - Guo, X. AU - Xiong, L. AU - Yu, L. AU - Li, Z. AU - Guo, Q. AU - Li, Z. AU - Li, B. AU - Lin, N. PY - 2014 DA - 2014// TI - Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway JO - Mol Cancer VL - 13 UR - https://doi.org/10.1186/1476-4598-13-253 DO - 10.1186/1476-4598-13-253 ID - Zhang2014 ER - TY - JOUR AU - Jin, L. AU - Hu, W. L. AU - Jiang, C. C. PY - 2011 DA - 2011// TI - MicroRNA-149*, a p53-responsive microRNA, functions as an oncogenic regulator in human melanoma JO - Proc Natl Acad Sci U S A VL - 108 UR - https://doi.org/10.1073/pnas.1019312108 DO - 10.1073/pnas.1019312108 ID - Jin2011 ER - TY - JOUR AU - Zhi, Y. AU - Zhou, H. AU - Mubalake, A. AU - Chen, Y. AU - Zhang, B. AU - Zhang, K. AU - Chu, X. AU - Wang, R. PY - 2018 DA - 2018// TI - Regulation and functions of MicroRNA-149 in human cancers JO - Cell Prolif VL - 51 UR - https://doi.org/10.1111/cpr.12465 DO - 10.1111/cpr.12465 ID - Zhi2018 ER - TY - JOUR AU - Ding, H. AU - Zheng, S. AU - Garcia-Ruiz, D. PY - 2016 DA - 2016// TI - Fasting induces a subcutaneous-to-visceral fat switch mediated by microRNA-149-3p and suppression of PRDM16 JO - Nat Commun VL - 7 UR - https://doi.org/10.1038/ncomms11533 DO - 10.1038/ncomms11533 ID - Ding2016 ER - TY - JOUR AU - Gao, M. AU - Ma, Y. AU - Cui, R. AU - Liu, D. PY - 2014 DA - 2014// TI - Hydrodynamic delivery of FGF21 gene alleviates obesity and fatty liver in mice fed a high-fat diet JO - J Control Release VL - 185 UR - https://doi.org/10.1016/j.jconrel.2014.03.047 DO - 10.1016/j.jconrel.2014.03.047 ID - Gao2014 ER - TY - JOUR AU - Jimenez, V. AU - Jambrina, C. AU - Casana, E. PY - 2018 DA - 2018// TI - FGF21 gene therapy as treatment for obesity and insulin resistance JO - EMBO Mol Med VL - 10 UR - https://doi.org/10.15252/emmm.201708791 DO - 10.15252/emmm.201708791 ID - Jimenez2018 ER - TY - JOUR AU - Li, H. AU - Dong, K. AU - Fang, Q. AU - Hou, X. AU - Zhou, M. AU - Bao, Y. AU - Xiang, K. AU - Xu, A. AU - Jia, W. PY - 2013 DA - 2013// TI - High serum level of fibroblast growth factor 21 is an independent predictor of non-alcoholic fatty liver disease: a 3-year prospective study in China JO - J Hepatol VL - 58 UR - https://doi.org/10.1016/j.jhep.2012.10.029 DO - 10.1016/j.jhep.2012.10.029 ID - Li2013 ER - TY - JOUR AU - Singhal, G. AU - Kumar, G. AU - Chan, S. AU - Fisher, F. M. AU - Ma, Y. AU - Vardeh, H. G. AU - Nasser, I. A. AU - Flier, J. S. AU - Maratos-Flier, E. PY - 2018 DA - 2018// TI - Deficiency of fibroblast growth factor 21 (FGF21) promotes hepatocellular carcinoma (HCC) in mice on a long term obesogenic diet JO - Mol Metab VL - 13 UR - https://doi.org/10.1016/j.molmet.2018.03.002 DO - 10.1016/j.molmet.2018.03.002 ID - Singhal2018 ER - TY - JOUR AU - Ye, D. AU - Wang, Y. AU - Li, H. AU - Jia, W. AU - Man, K. AU - Lo, C. M. AU - Wang, Y. AU - Lam, K. S. AU - Xu, A. PY - 2014 DA - 2014// TI - Fibroblast growth factor 21 protects against acetaminophen-induced hepatotoxicity by potentiating peroxisome proliferator-activated receptor coactivator protein-1alpha-mediated antioxidant capacity in mice JO - Hepatology VL - 60 UR - https://doi.org/10.1002/hep.27060 DO - 10.1002/hep.27060 ID - Ye2014 ER -